Fulgent Genetics Inc (FLGT)

$31.39 0.37 (1.19%)

12:27 EDT FLGT Stock Quote Delayed 30 Minutes

My Top 7 Strong Conviction Buys for 2023

By Chris Lau, InvestorPlace Contributor Dec 15, 2022

Companies that are down on their luck this year are in strong contention for conviction buys for 2023 as they rebound.

3 Smaller Most-Shorted Stocks to Buy

12 Most Highly Shorted Stocks Heading Into Q3 2021

8 High-Risk Stocks to Buy That Are Worth Taking a Chance On

More Articles

Volume:

Previous Close -

Market Cap 926.60M

PE Ratio -

EPS -

Volume (Avg. Vol.) 96,324

Day's Range $31.15 - $31.87

52-Week Range $28.53 - $65.32

Dividend & Yield N/A (N/A)

FLGT Stock Predictions, Articles, and Fulgent Genetics Inc News

From InvestorPlace
From the Web

7 Healthcare Stocks to Buy for Changing Demographics

By Louis Navellier and the InvestorPlace Research Staff Jun 11, 2021

These seven healthcare stocks are in a good position to take off as baby boomers continue to age into retirement.

8 High-Risk Stocks to Buy That Are Worth Taking A Chance On

By Louis Navellier and the InvestorPlace Research Staff Apr 6, 2021

A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential.

What Will the Stock Market Do Today? 3 Big Stories to Watch

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Mar 5, 2021

What will the stock market do today? It looks like investors are gearing up to dive into the jobs report and watch oil stocks rise.

FLGT Stock: 3 Reasons Why Fulgent Genetics Is Soaring Today

By William White, InvestorPlace Writer Mar 5, 2021

Fulgent Genetics (FLGT) stock is on the rise in pre-market trading and we know exactly why investors are so happy with the company.

7 Biotech Stocks Focused on Chronic Covid Treatment

By Thomas Niel, InvestorPlace Contributor Feb 22, 2021

Keep in mind downside risk, if their respective candidates fail to pan out. But, there may be opportunity with these seven biotech stocks targeting treatments for long-haul Covid-19.

Stock Winners: 5 Factors That Can Give You 10X Potential

By InvestorPlace Research Staff Feb 17, 2021

Here are five important factors to consider when you’re looking for the next big stock winners.

MoneyLine Podcast: An Unbiased Opinion on This Week’s Trading

By InvestorPlace Research Staff Jan 29, 2021

This has been an insane week for the stock market with some of the greatest volatility you have ever seen. In times like this it’s tough to know what to do. Matt McCall has some ideas.

7 of the Best Cheap Stocks for December

By Tezcan Gecgil, InvestorPlace Contributor Nov 25, 2020

Here are seven of the best cheap stocks for December that I'd consider buying

Why Fulgent Genetics Stock Can Keep Soaring

By Vince Martin, InvestorPlace Contributor Aug 25, 2020

Fulgent Genetics stock has gained 253% so far this year. Strong growth and a reasonable valuation suggest the rally will continue.

Let High Flyer Fulgent Genetics Take a Breather Before Dipping In

By David Moadel, InvestorPlace Contributor Aug 20, 2020

The demand for Covid-19 testing kits has been strong, and that's bullish for Fulgent Genetics stock, but don't just buy it at any price.

New Highs in a Key Sector Tell Us What’s to Come

By InvestorPlace Research Staff Dec 6, 2019

Strength in small-cap stocks is healthy for the market overall. It shows investors are comfortable with taking on risk in anticipation of worthwhile returns.

7 Next-Generation Healthcare Stocks to Buy

By Louis Navellier, Editor, Growth Investor Oct 3, 2019

These healthcare stocks are all worth a "buy" now. The healthcare sector will keep chugging along despite market volatility.

Fulgent Genetics Non-GAAP EPS of -$0.48 beats by $0.08, revenue of $67.7M beats by $8.13M (NASDAQ:FLGT)

From Seeking Alpha Feb 28, 2023

Fulgent Genetics press release (FLGT): Q4 Non-GAAP EPS of -$0.48 beats by $0.08.Revenue of $67.7M (-73.1% Y/Y) beats by $8.13M.Core Revenue grew 97% year-over-year to $55.0...

Which Is the Better Buy: Vertex or Invitae?

From The Motley Fool Dec 16, 2022

Is Vertex worth its lofty valuation compared to Invitae?

1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings

From The Motley Fool Nov 24, 2022

Strong core business growth was overshadowed in Q3 by an acquisition.

Fulgent Genetics: Q1 Earnings Insights

From Benzinga May 3, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat estimated earnings by 31.61%, reporting an EPS of $5.08 versus an estimate of $3.86.

Earnings Outlook For Fulgent Genetics

From Benzinga May 2, 2022

Fulgent Genetics (NASDAQ:FLGT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Fulgent Genetics will report an earnings per share (EPS) of $3.86.

Why Fulgent Genetics Shares Are Trading Higher Today

From Benzinga Apr 19, 2022